The global market for Hyperthyroidism Treatment was estimated to be worth US$ 453 million in 2023 and is forecast to a readjusted size of US$ 703.1 million by 2030 with a CAGR of 6.2% during the forecast period 2024-2030

Hyperthyroidism Treatment - Market

Antithyroid medications are drugs that are used to treat hyperthyroidism, a condition in which the thyroid gland produces too much thyroid hormone. These medications work by blocking the production of thyroid hormone in the thyroid gland.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hyperthyroidism Treatment, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Hyperthyroidism Treatment by region & country, by Type, and by Application.

The Hyperthyroidism Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hyperthyroidism Treatment.

Market Segmentation

Scope of Hyperthyroidism Treatment - Market Report

Report Metric	Details
Report Name	Hyperthyroidism Treatment - Market
Forecasted market size in 2030	US$ 703.1 million
CAGR	6.2%
Forecasted years	2024 - 2030
Segment by Type:	Methimazole Propylthiouracil Other
Segment by Application	Hospital Clinic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck, Herbrand PharmaChemicals, Shanghai Zhaohui Pharmaceutical, Beijing Yanjing Pharmaceutical, Jinghua Pharmaceutical Group, Guangzhou Kanghe Pharmaceutical, Zigong Honghe Pharmaceutical, Guangdong Huanan Pharmaceutical, Zibo Wankang Pharmaceutical Chemical, Qilu Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Hyperthyroidism Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Hyperthyroidism Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Hyperthyroidism Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Hyperthyroidism Treatment - Market size in 2030?

Ans: The Hyperthyroidism Treatment - Market size in 2030 will be US$ 703.1 million.

Who are the main players in the Hyperthyroidism Treatment - Market report?

Ans: The main players in the Hyperthyroidism Treatment - Market are Merck, Herbrand PharmaChemicals, Shanghai Zhaohui Pharmaceutical, Beijing Yanjing Pharmaceutical, Jinghua Pharmaceutical Group, Guangzhou Kanghe Pharmaceutical, Zigong Honghe Pharmaceutical, Guangdong Huanan Pharmaceutical, Zibo Wankang Pharmaceutical Chemical, Qilu Pharmaceutical

What are the Application segmentation covered in the Hyperthyroidism Treatment - Market report?

Ans: The Applications covered in the Hyperthyroidism Treatment - Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Hyperthyroidism Treatment - Market report?

Ans: The Types covered in the Hyperthyroidism Treatment - Market report are Methimazole, Propylthiouracil, Other

1 Market Overview

1.1 Hyperthyroidism Treatment Product Introduction

1.2 Global Hyperthyroidism Treatment Market Size Forecast

1.2.1 Global Hyperthyroidism Treatment Sales Value (2019-2030)

1.2.2 Global Hyperthyroidism Treatment Sales Volume (2019-2030)

1.2.3 Global Hyperthyroidism Treatment Sales Price (2019-2030)

1.3 Hyperthyroidism Treatment Market Trends & Drivers

1.3.1 Hyperthyroidism Treatment Industry Trends

1.3.2 Hyperthyroidism Treatment Market Drivers & Opportunity

1.3.3 Hyperthyroidism Treatment Market Challenges

1.3.4 Hyperthyroidism Treatment Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Hyperthyroidism Treatment Players Revenue Ranking (2023)

2.2 Global Hyperthyroidism Treatment Revenue by Company (2019-2024)

2.3 Global Hyperthyroidism Treatment Players Sales Volume Ranking (2023)

2.4 Global Hyperthyroidism Treatment Sales Volume by Company Players (2019-2024)

2.5 Global Hyperthyroidism Treatment Average Price by Company (2019-2024)

2.6 Key Manufacturers Hyperthyroidism Treatment Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Hyperthyroidism Treatment Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Hyperthyroidism Treatment

2.9 Hyperthyroidism Treatment Market Competitive Analysis

2.9.1 Hyperthyroidism Treatment Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Hyperthyroidism Treatment Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyperthyroidism Treatment as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Methimazole

3.1.2 Propylthiouracil

3.1.3 Other

3.2 Global Hyperthyroidism Treatment Sales Value by Type

3.2.1 Global Hyperthyroidism Treatment Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Hyperthyroidism Treatment Sales Value, by Type (2019-2030)

3.2.3 Global Hyperthyroidism Treatment Sales Value, by Type (%) (2019-2030)

3.3 Global Hyperthyroidism Treatment Sales Volume by Type

3.3.1 Global Hyperthyroidism Treatment Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Hyperthyroidism Treatment Sales Volume, by Type (2019-2030)

3.3.3 Global Hyperthyroidism Treatment Sales Volume, by Type (%) (2019-2030)

3.4 Global Hyperthyroidism Treatment Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Clinic

4.1.3 Other

4.2 Global Hyperthyroidism Treatment Sales Value by Application

4.2.1 Global Hyperthyroidism Treatment Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Hyperthyroidism Treatment Sales Value, by Application (2019-2030)

4.2.3 Global Hyperthyroidism Treatment Sales Value, by Application (%) (2019-2030)

4.3 Global Hyperthyroidism Treatment Sales Volume by Application

4.3.1 Global Hyperthyroidism Treatment Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Hyperthyroidism Treatment Sales Volume, by Application (2019-2030)

4.3.3 Global Hyperthyroidism Treatment Sales Volume, by Application (%) (2019-2030)

4.4 Global Hyperthyroidism Treatment Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Hyperthyroidism Treatment Sales Value by Region

5.1.1 Global Hyperthyroidism Treatment Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Hyperthyroidism Treatment Sales Value by Region (2019-2024)

5.1.3 Global Hyperthyroidism Treatment Sales Value by Region (2025-2030)

5.1.4 Global Hyperthyroidism Treatment Sales Value by Region (%), (2019-2030)

5.2 Global Hyperthyroidism Treatment Sales Volume by Region

5.2.1 Global Hyperthyroidism Treatment Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Hyperthyroidism Treatment Sales Volume by Region (2019-2024)

5.2.3 Global Hyperthyroidism Treatment Sales Volume by Region (2025-2030)

5.2.4 Global Hyperthyroidism Treatment Sales Volume by Region (%), (2019-2030)

5.3 Global Hyperthyroidism Treatment Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Hyperthyroidism Treatment Sales Value, 2019-2030

5.4.2 North America Hyperthyroidism Treatment Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Hyperthyroidism Treatment Sales Value, 2019-2030

5.5.2 Europe Hyperthyroidism Treatment Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Hyperthyroidism Treatment Sales Value, 2019-2030

5.6.2 Asia Pacific Hyperthyroidism Treatment Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Hyperthyroidism Treatment Sales Value, 2019-2030

5.7.2 South America Hyperthyroidism Treatment Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Hyperthyroidism Treatment Sales Value, 2019-2030

5.8.2 Middle East & Africa Hyperthyroidism Treatment Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Hyperthyroidism Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Hyperthyroidism Treatment Sales Value

6.2.1 Key Countries/Regions Hyperthyroidism Treatment Sales Value, 2019-2030

6.2.2 Key Countries/Regions Hyperthyroidism Treatment Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Hyperthyroidism Treatment Sales Value, 2019-2030

6.3.2 United States Hyperthyroidism Treatment Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Hyperthyroidism Treatment Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Hyperthyroidism Treatment Sales Value, 2019-2030

6.4.2 Europe Hyperthyroidism Treatment Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Hyperthyroidism Treatment Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Hyperthyroidism Treatment Sales Value, 2019-2030

6.5.2 China Hyperthyroidism Treatment Sales Value by Type (%), 2023 VS 2030

6.5.3 China Hyperthyroidism Treatment Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Hyperthyroidism Treatment Sales Value, 2019-2030

6.6.2 Japan Hyperthyroidism Treatment Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Hyperthyroidism Treatment Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Hyperthyroidism Treatment Sales Value, 2019-2030

6.7.2 South Korea Hyperthyroidism Treatment Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Hyperthyroidism Treatment Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Hyperthyroidism Treatment Sales Value, 2019-2030

6.8.2 Southeast Asia Hyperthyroidism Treatment Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Hyperthyroidism Treatment Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Hyperthyroidism Treatment Sales Value, 2019-2030

6.9.2 India Hyperthyroidism Treatment Sales Value by Type (%), 2023 VS 2030

6.9.3 India Hyperthyroidism Treatment Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Merck

7.1.1 Merck Company Information

7.1.2 Merck Introduction and Business Overview

7.1.3 Merck Hyperthyroidism Treatment Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Merck Hyperthyroidism Treatment Product Offerings

7.1.5 Merck Recent Development

7.2 Herbrand PharmaChemicals

7.2.1 Herbrand PharmaChemicals Company Information

7.2.2 Herbrand PharmaChemicals Introduction and Business Overview

7.2.3 Herbrand PharmaChemicals Hyperthyroidism Treatment Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Herbrand PharmaChemicals Hyperthyroidism Treatment Product Offerings

7.2.5 Herbrand PharmaChemicals Recent Development

7.3 Shanghai Zhaohui Pharmaceutical

7.3.1 Shanghai Zhaohui Pharmaceutical Company Information

7.3.2 Shanghai Zhaohui Pharmaceutical Introduction and Business Overview

7.3.3 Shanghai Zhaohui Pharmaceutical Hyperthyroidism Treatment Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Shanghai Zhaohui Pharmaceutical Hyperthyroidism Treatment Product Offerings

7.3.5 Shanghai Zhaohui Pharmaceutical Recent Development

7.4 Beijing Yanjing Pharmaceutical

7.4.1 Beijing Yanjing Pharmaceutical Company Information

7.4.2 Beijing Yanjing Pharmaceutical Introduction and Business Overview

7.4.3 Beijing Yanjing Pharmaceutical Hyperthyroidism Treatment Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Beijing Yanjing Pharmaceutical Hyperthyroidism Treatment Product Offerings

7.4.5 Beijing Yanjing Pharmaceutical Recent Development

7.5 Jinghua Pharmaceutical Group

7.5.1 Jinghua Pharmaceutical Group Company Information

7.5.2 Jinghua Pharmaceutical Group Introduction and Business Overview

7.5.3 Jinghua Pharmaceutical Group Hyperthyroidism Treatment Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Jinghua Pharmaceutical Group Hyperthyroidism Treatment Product Offerings

7.5.5 Jinghua Pharmaceutical Group Recent Development

7.6 Guangzhou Kanghe Pharmaceutical

7.6.1 Guangzhou Kanghe Pharmaceutical Company Information

7.6.2 Guangzhou Kanghe Pharmaceutical Introduction and Business Overview

7.6.3 Guangzhou Kanghe Pharmaceutical Hyperthyroidism Treatment Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Guangzhou Kanghe Pharmaceutical Hyperthyroidism Treatment Product Offerings

7.6.5 Guangzhou Kanghe Pharmaceutical Recent Development

7.7 Zigong Honghe Pharmaceutical

7.7.1 Zigong Honghe Pharmaceutical Company Information

7.7.2 Zigong Honghe Pharmaceutical Introduction and Business Overview

7.7.3 Zigong Honghe Pharmaceutical Hyperthyroidism Treatment Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Zigong Honghe Pharmaceutical Hyperthyroidism Treatment Product Offerings

7.7.5 Zigong Honghe Pharmaceutical Recent Development

7.8 Guangdong Huanan Pharmaceutical

7.8.1 Guangdong Huanan Pharmaceutical Company Information

7.8.2 Guangdong Huanan Pharmaceutical Introduction and Business Overview

7.8.3 Guangdong Huanan Pharmaceutical Hyperthyroidism Treatment Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Guangdong Huanan Pharmaceutical Hyperthyroidism Treatment Product Offerings

7.8.5 Guangdong Huanan Pharmaceutical Recent Development

7.9 Zibo Wankang Pharmaceutical Chemical

7.9.1 Zibo Wankang Pharmaceutical Chemical Company Information

7.9.2 Zibo Wankang Pharmaceutical Chemical Introduction and Business Overview

7.9.3 Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Treatment Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Treatment Product Offerings

7.9.5 Zibo Wankang Pharmaceutical Chemical Recent Development

7.10 Qilu Pharmaceutical

7.10.1 Qilu Pharmaceutical Company Information

7.10.2 Qilu Pharmaceutical Introduction and Business Overview

7.10.3 Qilu Pharmaceutical Hyperthyroidism Treatment Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Qilu Pharmaceutical Hyperthyroidism Treatment Product Offerings

7.10.5 Qilu Pharmaceutical Recent Development

8 Industry Chain Analysis

8.1 Hyperthyroidism Treatment Industrial Chain

8.2 Hyperthyroidism Treatment Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Hyperthyroidism Treatment Sales Model

8.5.2 Sales Channel

8.5.3 Hyperthyroidism Treatment Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Merck

Herbrand PharmaChemicals

Shanghai Zhaohui Pharmaceutical

Beijing Yanjing Pharmaceutical

Jinghua Pharmaceutical Group

Guangzhou Kanghe Pharmaceutical

Zigong Honghe Pharmaceutical

Guangdong Huanan Pharmaceutical

Zibo Wankang Pharmaceutical Chemical

Qilu Pharmaceutical

List of Tables

Table 1. Hyperthyroidism Treatment Market Trends

Table 2. Hyperthyroidism Treatment Market Drivers & Opportunity

Table 3. Hyperthyroidism Treatment Market Challenges

Table 4. Hyperthyroidism Treatment Market Restraints

Table 5. Global Hyperthyroidism Treatment Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Hyperthyroidism Treatment Revenue Market Share by Company (2019-2024)

Table 7. Global Hyperthyroidism Treatment Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Hyperthyroidism Treatment Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Hyperthyroidism Treatment Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Hyperthyroidism Treatment Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Hyperthyroidism Treatment Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Hyperthyroidism Treatment

Table 13. Global Hyperthyroidism Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyperthyroidism Treatment as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Hyperthyroidism Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Hyperthyroidism Treatment Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Hyperthyroidism Treatment Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Hyperthyroidism Treatment Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Hyperthyroidism Treatment Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Hyperthyroidism Treatment Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Hyperthyroidism Treatment Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Hyperthyroidism Treatment Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Hyperthyroidism Treatment Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Hyperthyroidism Treatment Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Hyperthyroidism Treatment Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Hyperthyroidism Treatment Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Hyperthyroidism Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Hyperthyroidism Treatment Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Hyperthyroidism Treatment Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Hyperthyroidism Treatment Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Hyperthyroidism Treatment Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Hyperthyroidism Treatment Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Hyperthyroidism Treatment Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Hyperthyroidism Treatment Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Hyperthyroidism Treatment Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Hyperthyroidism Treatment Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Hyperthyroidism Treatment Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Hyperthyroidism Treatment Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Hyperthyroidism Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Hyperthyroidism Treatment Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Hyperthyroidism Treatment Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Hyperthyroidism Treatment Sales Value by Region (2019-2024) & (%)

Table 44. Global Hyperthyroidism Treatment Sales Value by Region (2025-2030) & (%)

Table 45. Global Hyperthyroidism Treatment Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Hyperthyroidism Treatment Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Hyperthyroidism Treatment Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Hyperthyroidism Treatment Sales Volume by Region (2019-2024) & (%)

Table 49. Global Hyperthyroidism Treatment Sales Volume by Region (2025-2030) & (%)

Table 50. Global Hyperthyroidism Treatment Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Hyperthyroidism Treatment Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Hyperthyroidism Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Hyperthyroidism Treatment Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Hyperthyroidism Treatment Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Hyperthyroidism Treatment Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Hyperthyroidism Treatment Sales Volume, (2025-2030) & (K Units)

Table 57. Merck Company Information

Table 58. Merck Introduction and Business Overview

Table 59. Merck Hyperthyroidism Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Merck Hyperthyroidism Treatment Product Offerings

Table 61. Merck Recent Development

Table 62. Herbrand PharmaChemicals Company Information

Table 63. Herbrand PharmaChemicals Introduction and Business Overview

Table 64. Herbrand PharmaChemicals Hyperthyroidism Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Herbrand PharmaChemicals Hyperthyroidism Treatment Product Offerings

Table 66. Herbrand PharmaChemicals Recent Development

Table 67. Shanghai Zhaohui Pharmaceutical Company Information

Table 68. Shanghai Zhaohui Pharmaceutical Introduction and Business Overview

Table 69. Shanghai Zhaohui Pharmaceutical Hyperthyroidism Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Shanghai Zhaohui Pharmaceutical Hyperthyroidism Treatment Product Offerings

Table 71. Shanghai Zhaohui Pharmaceutical Recent Development

Table 72. Beijing Yanjing Pharmaceutical Company Information

Table 73. Beijing Yanjing Pharmaceutical Introduction and Business Overview

Table 74. Beijing Yanjing Pharmaceutical Hyperthyroidism Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Beijing Yanjing Pharmaceutical Hyperthyroidism Treatment Product Offerings

Table 76. Beijing Yanjing Pharmaceutical Recent Development

Table 77. Jinghua Pharmaceutical Group Company Information

Table 78. Jinghua Pharmaceutical Group Introduction and Business Overview

Table 79. Jinghua Pharmaceutical Group Hyperthyroidism Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Jinghua Pharmaceutical Group Hyperthyroidism Treatment Product Offerings

Table 81. Jinghua Pharmaceutical Group Recent Development

Table 82. Guangzhou Kanghe Pharmaceutical Company Information

Table 83. Guangzhou Kanghe Pharmaceutical Introduction and Business Overview

Table 84. Guangzhou Kanghe Pharmaceutical Hyperthyroidism Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Guangzhou Kanghe Pharmaceutical Hyperthyroidism Treatment Product Offerings

Table 86. Guangzhou Kanghe Pharmaceutical Recent Development

Table 87. Zigong Honghe Pharmaceutical Company Information

Table 88. Zigong Honghe Pharmaceutical Introduction and Business Overview

Table 89. Zigong Honghe Pharmaceutical Hyperthyroidism Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Zigong Honghe Pharmaceutical Hyperthyroidism Treatment Product Offerings

Table 91. Zigong Honghe Pharmaceutical Recent Development

Table 92. Guangdong Huanan Pharmaceutical Company Information

Table 93. Guangdong Huanan Pharmaceutical Introduction and Business Overview

Table 94. Guangdong Huanan Pharmaceutical Hyperthyroidism Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Guangdong Huanan Pharmaceutical Hyperthyroidism Treatment Product Offerings

Table 96. Guangdong Huanan Pharmaceutical Recent Development

Table 97. Zibo Wankang Pharmaceutical Chemical Company Information

Table 98. Zibo Wankang Pharmaceutical Chemical Introduction and Business Overview

Table 99. Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Treatment Product Offerings

Table 101. Zibo Wankang Pharmaceutical Chemical Recent Development

Table 102. Qilu Pharmaceutical Company Information

Table 103. Qilu Pharmaceutical Introduction and Business Overview

Table 104. Qilu Pharmaceutical Hyperthyroidism Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Qilu Pharmaceutical Hyperthyroidism Treatment Product Offerings

Table 106. Qilu Pharmaceutical Recent Development

Table 107. Key Raw Materials Lists

Table 108. Raw Materials Key Suppliers Lists

Table 109. Hyperthyroidism Treatment Downstream Customers

Table 110. Hyperthyroidism Treatment Distributors List

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Hyperthyroidism Treatment Product Picture

Figure 2. Global Hyperthyroidism Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Hyperthyroidism Treatment Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Hyperthyroidism Treatment Sales Volume (2019-2030) & (K Units)

Figure 5. Global Hyperthyroidism Treatment Sales Price (2019-2030) & (US$/Unit)

Figure 6. Hyperthyroidism Treatment Report Years Considered

Figure 7. Global Hyperthyroidism Treatment Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Hyperthyroidism Treatment Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Hyperthyroidism Treatment Revenue in 2023

Figure 10. Hyperthyroidism Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Methimazole Picture

Figure 12. Propylthiouracil Picture

Figure 13. Other Picture

Figure 14. Global Hyperthyroidism Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 15. Global Hyperthyroidism Treatment Sales Value Market Share by Type, 2023 & 2030

Figure 16. Global Hyperthyroidism Treatment Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 17. Global Hyperthyroidism Treatment Sales Volume Market Share by Type, 2023 & 2030

Figure 18. Global Hyperthyroidism Treatment Price by Type (2019-2030) & (US$/Unit)

Figure 19. Product Picture of Hospital

Figure 20. Product Picture of Clinic

Figure 21. Product Picture of Other

Figure 22. Global Hyperthyroidism Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 23. Global Hyperthyroidism Treatment Sales Value Market Share by Application, 2023 & 2030

Figure 24. Global Hyperthyroidism Treatment Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 25. Global Hyperthyroidism Treatment Sales Volume Market Share by Application, 2023 & 2030

Figure 26. Global Hyperthyroidism Treatment Price by Application (2019-2030) & (US$/Unit)

Figure 27. North America Hyperthyroidism Treatment Sales Value (2019-2030) & (US$ Million)

Figure 28. North America Hyperthyroidism Treatment Sales Value by Country (%), 2023 VS 2030

Figure 29. Europe Hyperthyroidism Treatment Sales Value (2019-2030) & (US$ Million)

Figure 30. Europe Hyperthyroidism Treatment Sales Value by Country (%), 2023 VS 2030

Figure 31. Asia Pacific Hyperthyroidism Treatment Sales Value (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Hyperthyroidism Treatment Sales Value by Country (%), 2023 VS 2030

Figure 33. South America Hyperthyroidism Treatment Sales Value (2019-2030) & (US$ Million)

Figure 34. South America Hyperthyroidism Treatment Sales Value by Country (%), 2023 VS 2030

Figure 35. Middle East & Africa Hyperthyroidism Treatment Sales Value (2019-2030) & (US$ Million)

Figure 36. Middle East & Africa Hyperthyroidism Treatment Sales Value by Country (%), 2023 VS 2030

Figure 37. Key Countries/Regions Hyperthyroidism Treatment Sales Value (%), (2019-2030)

Figure 38. Key Countries/Regions Hyperthyroidism Treatment Sales Volume (%), (2019-2030)

Figure 39. United States Hyperthyroidism Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 40. United States Hyperthyroidism Treatment Sales Value by Type (%), 2023 VS 2030

Figure 41. United States Hyperthyroidism Treatment Sales Value by Application (%), 2023 VS 2030

Figure 42. Europe Hyperthyroidism Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 43. Europe Hyperthyroidism Treatment Sales Value by Type (%), 2023 VS 2030

Figure 44. Europe Hyperthyroidism Treatment Sales Value by Application (%), 2023 VS 2030

Figure 45. China Hyperthyroidism Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 46. China Hyperthyroidism Treatment Sales Value by Type (%), 2023 VS 2030

Figure 47. China Hyperthyroidism Treatment Sales Value by Application (%), 2023 VS 2030

Figure 48. Japan Hyperthyroidism Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 49. Japan Hyperthyroidism Treatment Sales Value by Type (%), 2023 VS 2030

Figure 50. Japan Hyperthyroidism Treatment Sales Value by Application (%), 2023 VS 2030

Figure 51. South Korea Hyperthyroidism Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 52. South Korea Hyperthyroidism Treatment Sales Value by Type (%), 2023 VS 2030

Figure 53. South Korea Hyperthyroidism Treatment Sales Value by Application (%), 2023 VS 2030

Figure 54. Southeast Asia Hyperthyroidism Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 55. Southeast Asia Hyperthyroidism Treatment Sales Value by Type (%), 2023 VS 2030

Figure 56. Southeast Asia Hyperthyroidism Treatment Sales Value by Application (%), 2023 VS 2030

Figure 57. India Hyperthyroidism Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 58. India Hyperthyroidism Treatment Sales Value by Type (%), 2023 VS 2030

Figure 59. India Hyperthyroidism Treatment Sales Value by Application (%), 2023 VS 2030

Figure 60. Hyperthyroidism Treatment Industrial Chain

Figure 61. Hyperthyroidism Treatment Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-19K14366

Thu Oct 17 00:00:00 UTC 2024

Add to Cart

Hyperthyroidism Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-10V14301

Thu Oct 17 00:00:00 UTC 2024

Add to Cart

Dipeptidyl Peptidase-4 Inhibitors - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-24J13911

Thu Oct 17 00:00:00 UTC 2024

Add to Cart

Oral Hypoglycemic Medications - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-32J13966

Thu Oct 17 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Hyperthyroidism Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: October 2024

Report Code: QYRE-Auto-10V14301

Hyperthyroidism Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

FEATURED COMPANIES

Hyperthyroidism Treatment - Market Size

Hyperthyroidism Treatment - Market

Report Scope

Scope of Hyperthyroidism Treatment - Market Report

Chapter Outline

FAQ for this report

What is the Hyperthyroidism Treatment - Market size in 2030?

Who are the main players in the Hyperthyroidism Treatment - Market report?

What are the Application segmentation covered in the Hyperthyroidism Treatment - Market report?

What are the Type segmentation covered in the Hyperthyroidism Treatment - Market report?

FEATURED COMPANIES

RELATED REPORTS